Evidence map›Paper›PMID 36140676›Full record

ArticleGenes2022

SPACR Encoded by

Guillaume Olivier, Philippe Brabet, Nelly Pirot, Morgane Broyon, Laurent Guillou, Chantal Cazevieille, Chamroeun Sar, Melanie Quiles, Emmanuelle Sarzi, Marie Pequignot and 6 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Genes, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 2 institutions in 1 country.

Guillaume OlivierInstitute for Neurosciences of Montpellier (INM), Institut National de la Santé et de la Recherche Médicale (INSERM), University of Montpellier, 34091 Montpellier, France.
Philippe BrabetInstitute for Neurosciences of Montpellier (INM), Institut National de la Santé et de la Recherche Médicale (INSERM), University of Montpellier, 34091 Montpellier, France.ORCID 0000-0003-2739-1622
Nelly PirotRHEM, IRCM-INSERM, 34000 Montpellier, France.
Morgane BroyonRHEM, IRCM-INSERM, 34000 Montpellier, France.
Laurent GuillouInstitute for Neurosciences of Montpellier (INM), Institut National de la Santé et de la Recherche Médicale (INSERM), University of Montpellier, 34091 Montpellier, France.
Chantal CazevieilleInstitute for Neurosciences of Montpellier (INM), Institut National de la Santé et de la Recherche Médicale (INSERM), University of Montpellier, 34091 Montpellier, France.
Chamroeun SarInstitute for Neurosciences of Montpellier (INM), Institut National de la Santé et de la Recherche Médicale (INSERM), University of Montpellier, 34091 Montpellier, France.
Melanie QuilesInstitute for Neurosciences of Montpellier (INM), Institut National de la Santé et de la Recherche Médicale (INSERM), University of Montpellier, 34091 Montpellier, France.
Emmanuelle SarziINSERM, University Claude Bernard, 69100 Lyon, France.
Marie PequignotInstitute for Neurosciences of Montpellier (INM), Institut National de la Santé et de la Recherche Médicale (INSERM), University of Montpellier, 34091 Montpellier, France.
Ervann AndreoInstitute for Neurosciences of Montpellier (INM), Institut National de la Santé et de la Recherche Médicale (INSERM), University of Montpellier, 34091 Montpellier, France.
Agathe RoubertieInstitute for Neurosciences of Montpellier (INM), Institut National de la Santé et de la Recherche Médicale (INSERM), University of Montpellier, 34091 Montpellier, France.
Isabelle MeunierInstitute for Neurosciences of Montpellier (INM), Institut National de la Santé et de la Recherche Médicale (INSERM), University of Montpellier, 34091 Montpellier, France.ORCID 0000-0003-3407-5265
Agnès MullerInstitute for Neurosciences of Montpellier (INM), Institut National de la Santé et de la Recherche Médicale (INSERM), University of Montpellier, 34091 Montpellier, France.
Vasiliki KalatzisInstitute for Neurosciences of Montpellier (INM), Institut National de la Santé et de la Recherche Médicale (INSERM), University of Montpellier, 34091 Montpellier, France.ORCID 0000-0002-9626-8807
Gaël ManesInstitute for Neurosciences of Montpellier (INM), Institut National de la Santé et de la Recherche Médicale (INSERM), University of Montpellier, 34091 Montpellier, France.ORCID 0000-0003-1871-0636
Inserm · FRUniversité Claude Bernard Lyon 1 · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Several pathogenic variants have been reported in the

Indexed as

Extracellular Matrix ProteinsEye ProteinsProteoglycansRetinitis PigmentosaVitelliform Macular DystrophyAnimalsExtracellular MatrixMicePhotoreceptor CellsRetinaldehydeRetinal Pigment EpitheliumRetinal PigmentsExtracellular Matrix ProteinsEye ProteinsIMPG1 protein, mouseProteoglycansRetinaldehydeRetinal PigmentsIMPG1IMPG2retinitis pigmentosaSPACRSPACRCANvitelliform macular dystrophy

Identifiers

PMID36140676
PMCPMC9498744
OpenAlexW4293030604

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.